+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID07468136

Phase IIIa Trial Evaluating Retifanlimab With or Without DFMO for Treating Progressive High-Grade Gliomas

Led by Mayo Clinic · Updated on 2026-06-24

33

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating retifanlimab, with or without difluoromethylornithine DFMO, for treating progressive high-grade gliomas, which are aggressive brain tumors that grow, spread, or worsen over time. This phase III trial is testing the safety, side effects, best dose, and immune effects of these treatments. Retifanlimab is an immunotherapy that may help the immune system attack the tumor, while DFMO blocks signals that encourage tumor cell multiplication. Participants receive retifanlimab intravenously, with some groups also taking DFMO orally every 8 hours on specified days during 28-day cycles. After initial treatment, patients undergo standard surgical tumor removal resection as part of routine care. Following surgery, retifanlimab and DFMO are given again in repeated cycles for up to 16 additional cycles if the disease does not progress and side effects are manageable. Optional procedures include MRI scans, blood tests, and cerebrospinal fluid collection to monitor disease and treatment effects. Throughout the study, participants are regularly evaluated with imaging and blood samples, and some may have cerebrospinal fluid collected. Researchers measure the best tolerable dose of DFMO and changes in immune cell ratios over up to five years. Safety, side effects, progression-free survival, and immune markers are also tracked. Participants need to be able to complete study forms and return for follow-up visits during active monitoring, which may last several years.

CONDITIONS

Brief Title

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Research Team

C

Clinical Trials Referral Office

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here